PLRX - Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and markets new therapies for the treatment of fibrosis and related diseases in the United States. The company is headquartered in South San Francisco, California.

52W High

$16.10

52W Low

$1.10

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.44

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-2.54

EV/Revenue (<3 favorable)

1376.69

P/S (TTM) (<3 favorable)

3071.82

P/B (<3 favorable)

0.52

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

3.04%

Institutions (25–75% balanced)

85.71%

Shares Outstanding

61,388,000

Float

55,573,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-3.38

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.68%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-1.00

Momentum

Bearish momentum

Value

0.0412

0.0554

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025